Cargando…

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Tate, Mitchel, Prakoso, Darnel, Willis, Andrew M., Peng, Cheng, Deo, Minh, Qin, Cheng Xue, Walsh, Jesse L., Nash, David M., Cohen, Charles D., Rofe, Alex K., Sharma, Arpeeta, Kiriazis, Helen, Donner, Daniel G., De Haan, Judy B., Watson, Anna M. D., De Blasio, Miles J., Ritchie, Rebecca H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417435/ https://www.ncbi.nlm.nih.gov/pubmed/34489742 http://dx.doi.org/10.3389/fphys.2021.734320

Ejemplares similares

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2019)

Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
por: Parker, Alex M., et al.
Publicado: (2021)

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021)

Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes
por: De Blasio, Miles J., et al.
Publicado: (2020)

Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
por: Cohen, Charles D., et al.
Publicado: (2023)

The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart
por: Tate, Mitchel, et al.
Publicado: (2019)

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2021)

Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities
por: Sharma, Arpeeta, et al.
Publicado: (2023)

Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
por: Qin, Cheng Xue, et al.
Publicado: (2017)

Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
por: Qin, Cheng Xue, et al.
Publicado: (2018)

Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition
por: Cohen, Charles D., et al.
Publicado: (2021)

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
por: Sharma, Arpeeta, et al.
Publicado: (2018)

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
por: Sharma, Arpeeta, et al.
Publicado: (2017)

Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
por: Pickering, Raelene J, et al.
Publicado: (2018)

Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2012)

Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac(2-26), Against Myocardial Infarction
por: Qin, Cheng Xue, et al.
Publicado: (2019)

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2017)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
por: Sharma, Arpeeta, et al.
Publicado: (2023)

Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease
por: Østergaard, Jakob A., et al.
Publicado: (2022)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019)

The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice
por: Tan, Sih Min, et al.
Publicado: (2013)

In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
por: Bernardo, Bianca C., et al.
Publicado: (2022)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
por: Huynh, Karina, et al.
Publicado: (2010)

Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Characterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysis
por: Odudu, Aghogho, et al.
Publicado: (2015)

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication()()
por: Goette, Andreas, et al.
Publicado: (2016)

Predictors of return to work following motor vehicle related orthopaedic trauma
por: Murgatroyd, Darnel F., et al.
Publicado: (2016)

Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age
por: van der Pols, M. J., et al.
Publicado: (2016)

NFκB Inhibition Mitigates Serum Amyloid A-Induced Pro-Atherogenic Responses in Endothelial Cells and Leukocyte Adhesion and Adverse Changes to Endothelium Function in Isolated Aorta
por: Vallejo, Abigail, et al.
Publicado: (2018)

Effect of sodium bisulfate amendments on bacterial populations in broiler litter
por: Joerger, Rolf D., et al.
Publicado: (2020)

Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study
por: Sharma, Abhipree, et al.
Publicado: (2023)

N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
por: Giam, Beverly, et al.
Publicado: (2017)

Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma
por: Van Laar, Ryan, et al.
Publicado: (2019)

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
por: Komiyama, Maki, et al.
Publicado: (2020)

Left ventricular non-compaction cardiomyopathy in adults – characterisation by cardiac magnetic resonance imaging
por: Merten, Constanze, et al.
Publicado: (2009)

Electronic cigarettes: product characterisation and design considerations
por: Brown, Christopher J, et al.
Publicado: (2014)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
por: Nguyen, My-Nhan, et al.
Publicado: (2018)

SOD2 in skeletal muscle: New insights from an inducible deletion model
por: Zhuang, Aowen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lkohnenom3i1u11g6t5boptbt6